Evidence Based Herbal and Nutritional Treatments for Anxiety in Psychiatric Disorders 1st Edition by David Camfield, Erica McIntyre, Jerome Sarris – Ebook PDF Instant Download/DeliveryISBN: 3319423074, 9783319423074
Full download Evidence Based Herbal and Nutritional Treatments for Anxiety in Psychiatric Disorders 1st Edition after payment.
Product details:
ISBN-10 : 3319423074
ISBN-13 : 9783319423074
Author: David Camfield, Erica McIntyre, Jerome Sarris
This book presents the current clinical evidence on the efficacy of herbal and nutritional treatments for anxiety that is experienced in association with psychiatric disorders, and explains how health professionals can apply this knowledge to the benefit of patients presenting with a wide range of symptoms, including comorbid mood disorders. All chapters are written by world-leading researchers who draw on the findings of human clinical trials to provide uncompromising assessments of individual treatments, including herbal anxiolytics with sedative actions, adaptogens, cognitive anxiolytics, and nutraceuticals. Traditional treatments requiring further study – including the plant-based psychotropic Ayahuasca and other phytotherapies of potential value in the treatment of anxiety – are also reviewed. In the closing chapters, a series of helpful case studies are provided by mental health clinicians in order to illustrate how herbal and nutritional treatments can best be integrated into an overall treatment plan for individuals with a range of comorbid diagnoses. Mental health professionals, researchers, and general readers will find that the book provides an excellent review of current scientific knowledge gained from the study of herbal and nutritional treatments, together with important clinical recommendations for their use in patients experiencing clinically significant levels of anxiety.
Evidence Based Herbal and Nutritional Treatments for Anxiety in Psychiatric Disorders 1st Table of contents:
1: The Need for Evidence-Based Herbal and Nutritional Anxiety Treatments in Psychiatry
1.1 The Experience of Anxiety
1.2 Limitations of Current Treatment Approaches
1.3 Nutritional and Herbal Treatments for Anxiety
1.4 Varied Mechanisms of Anxiolytic Actions
1.5 Challenges for an Emerging Herbal and Nutraceutical Industry
1.6 The Scope of This Book
References
Part I: Clinical Evidence in Support of Herbal and Nutritional Treatments for Anxiety
2: Herbal Anxiolytics with Sedative Actions
2.1 Introduction
2.2 Kava (Piper methysticum)
2.2.1 Overview
2.2.2 Mechanisms of Action
2.2.2.1 Constituents
2.2.3 Evidence of Efficacy
2.2.3.1 Anxiety
2.2.3.2 Mental Function
2.3 Passionflower (Passiflora incarnata)
2.3.1 Overview
2.3.2 Mechanisms of Action
2.3.2.1 In Vivo Studies
2.3.3 Evidence of Efficacy
2.3.3.1 Clinical Studies
2.4 Chamomile (Matricaria recutita)
2.4.1 Overview
2.4.2 Mechanisms of Action
2.4.3 Evidence of Efficacy
2.4.3.1 Clinical Studies
2.5 Galphimia (Galphimia glauca)
2.5.1 Overview
2.5.2 Mechanisms of Action
2.5.3 Evidence of Efficacy
2.5.3.1 Preclinical
2.5.3.2 Clinical
2.6 Skullcap (Scutellaria lateriflora)
2.6.1 Overview
2.6.2 Mechanisms of Action
2.7 Evidence of Efficacy
2.7.1 Preclinical
2.7.2 Clinical
2.8 Valerian (Valeriana spp.)
2.8.1 Overview
2.8.1.1 Mechanisms of Action
2.8.2 Evidence of Efficacy
2.8.3 Preclinical
2.8.3.1 Clinical
2.8.4 Clinical Considerations
References
3: Adaptogens
3.1 Introduction
3.2 Ashwagandha (Withania somnifera)
3.2.1 Overview
3.2.1.1 Mechanisms of Action
3.2.2 Evidence of Efficacy
3.2.2.1 Preclinical Studies
3.2.2.2 Clinical Studies
3.2.2.3 Safety
3.3 Roseroot (Rhodiola rosea)
3.3.1 Overview
3.3.1.1 Mechanism of Action
3.3.1.2 Preclinical Studies
3.3.1.3 Clinical Studies
3.3.1.4 Safety
3.4 Gotu Kola (Centella asiatica)
3.4.1 Overview
3.4.1.1 Mechanism of Action
3.4.1.2 Preclinical Studies
3.4.1.3 Clinical Studies
3.4.1.4 Safety
3.5 Siberian Ginseng (Eleutherococcus senticosus)
3.5.1 Mechanism of Action
3.5.2 Preclinical Studies
3.5.3 Clinical Studies
3.6 Schisandra (Schisandra chinensis)
3.6.1 Mechanism of Action
3.6.2 Preclinical Studies
3.6.3 Clinical Studies
3.6.4 Safety
3.7 Combination Preparations
3.7.1 Clinical Considerations
References
4: Cognitive Anxiolytics
4.1 Introduction
4.2 Brahmi (Bacopa monnieri)
4.2.1 Overview
4.2.2 Mechanisms of Action
4.2.3 Evidence of Efficacy
4.2.3.1 Preclinical
4.2.3.2 Acute Clinical Studies
4.2.3.3 Chronic Clinical Studies
4.2.4 Conclusion
4.3 Ginkgo (Ginkgo biloba)
4.3.1 Overview
4.3.2 Mechanisms of Action
4.3.2.1 Constituents
4.3.3 Evidence of Efficacy
4.3.3.1 Preclinical
4.3.3.2 Clinical
4.3.4 Conclusion
4.4 Lemon Balm (Melissa officinalis)
4.4.1 Overview
4.4.2 Mechanisms of Action
4.4.3 Evidence of Efficacy
4.4.3.1 Preclinical
4.4.3.2 Acute Studies in Non-clinical Adults
4.4.3.3 Research in Clinical Cohorts
4.4.4 Conclusion
4.5 Tea (Camellia sinensis)
4.5.1 Overview
4.5.2 Mechanisms of Action
4.5.2.1 Constituents
4.5.3 Evidence of Efficacy
4.5.3.1 Preclinical
4.5.3.2 Clinical
4.5.4 Conclusion
4.6 Sage (Salvia spp.)
4.6.1 Overview
4.6.2 Mechanisms of Action
4.6.2.1 Constituents
4.6.3 Evidence of Efficacy
4.6.3.1 Anxiety
4.6.3.2 Cognitive Function
4.6.4 Conclusion
4.7 Rosemary (Rosmarinus officinalis)
4.7.1 Overview
4.7.2 Mechanisms of Action
4.7.2.1 Constituents
4.7.3 Evidence of Efficacy
4.7.3.1 Cognitive Function
4.7.3.2 Anxiety
4.7.4 Conclusion
4.8 Clinical Considerations and Future Directions
References
5: Nutritional-Based Nutraceuticals in the Treatment of Anxiety
5.1 Introduction
5.2 B Vitamins
5.2.1 Overview
5.2.2 Mechanisms of Action (Constituents)
5.2.3 Evidence of Efficacy
5.2.3.1 Stress Reduction and Mood Improvements (Non-Clinical)
5.2.3.2 Depression
5.2.3.3 Anxiety
5.3 Magnesium
5.3.1 Overview
5.3.2 Mechanisms of Action
5.3.3 Evidence of Efficacy
5.4 Lysine and Arginine
5.4.1 Overview
5.4.2 Mechanisms of Action
5.4.3 Evidence of Efficacy
5.5 Myo-Inositol (MI)
5.5.1 Overview
5.5.2 Mechanisms of Action (Constituents)
5.5.2.1 Evidence of Efficacy
5.5.2.2 Panic Disorder
5.5.2.3 Post-traumatic Stress Disorder (PTSD)
5.5.2.4 Obsessive-Compulsive Disorder (OCD)
5.6 N-Acetylcysteine (NAC)
5.6.1 Overview
5.6.2 Mechanism of Action
5.6.3 Evidence of Efficacy
5.6.3.1 Generalized Anxiety Disorder and Social Phobia
5.6.3.2 Obsessive-Compulsive and Related Disorder
5.7 Clinical Considerations
References
6: Treatments for Comorbid Anxiety and Mood Disorders
6.1 Introduction
6.2 St John’s Wort (Hypericum perforatum)
6.2.1 Overview
6.2.2 Mechanisms of Action
6.2.2.1 Constituents
6.2.3 Evidence of Efficacy
6.2.3.1 Depression
6.2.3.2 Anxiety and Other Psychiatric Disorders
6.3 Saffron (Crocus sativus)
6.3.1 Overview
6.3.2 Mechanisms of Action
6.3.3 Evidence of Efficacy
6.4 Omega-3 Polyunsaturated Fatty Acids
6.4.1 Overview
6.4.2 Mechanisms of Action
6.4.3 Evidence of Efficacy
6.5 SAMe (S-Adenosyl methionine)
6.5.1 Overview
6.5.2 Mechanisms of Action
6.5.3 Evidence of Efficacy
6.5.3.1 Other Psychiatric Conditions
6.6 Zinc
6.6.1 Overview
6.6.2 Mechanisms of Action
6.6.3 Evidence of Efficacy
6.6.4 Clinical Considerations
References
Part II: Traditional Treatments in Need of Further Study
7: The Therapeutic Potential of Ayahuasca
7.1 Introduction
7.1.1 Constituents
7.1.2 Mechanisms of Action
7.2 Psycho-Socio-Cultural Significance of Ayahuasca and Scheduling of DMT
7.3 Modern Uses of Ayahuasca
7.4 Evidence of Efficacy
7.4.1 Therapeutic Effects Observed in the “Hoasca Project”
7.4.2 Anxiety and Panic
7.4.3 Depression
7.4.4 Substance Dependence
7.5 Conclusion and Clinical Considerations
References
8: Potential Herbal Anxiolytics
8.1 Introduction
8.2 Bitter Orange (Citrus aurantium)
8.2.1 Overview
8.2.2 Mechanisms of Action
8.2.3 In Vivo Studies
8.3 Evidence of Efficacy
8.3.1 Clinical Studies
8.4 Echinacea/Purple Cone Flower (Echinacea spp.)
8.4.1 Overview
8.4.2 Mechanisms of Action
8.4.3 In Vivo Studies
8.5 Evidence of Efficacy
8.5.1 Clinical Studies
8.6 Iranian Borage (Echium amoenum)
8.6.1 Overview
8.6.2 Mechanisms of Action
8.6.3 In Vivo Studies
8.7 Evidence of Efficacy
8.7.1 Clinical Studies
8.7.2 Milk Thistle (Silybum marianum)
8.7.2.1 Overview
8.7.2.2 Mechanisms of Action
8.8 Evidence of Efficacy
8.8.1 Preclinical
8.9 Evidence of Efficacy
8.9.1 Clinical Studies
8.10 Clinical Considerations
References
Part III: Clinical Perspectives and Case Studies
9: Integrative Treatments for Masked Anxiety and PTSD in Highly Sensitive Patients
9.1 Introduction
9.2 Clinical Cases
9.2.1 Case #1 Stress and Cervical Dystonia
9.2.1.1 Presenting Complaint
9.2.1.2 Diagnosis and Treatment Plan
9.2.1.3 Treatment Outcome
9.2.1.4 Discussion
9.2.2 Case #2 Posttraumatic Stress Disorder Hidden by a Cosmetic Life
9.2.2.1 Presenting Complaint
9.2.2.2 Diagnosis and Treatment Plan
9.2.2.3 Treatment Outcome
9.2.2.4 Discussion
9.2.3 Case #3 Anxiety Masked by Developmental Disorders
9.2.3.1 Presenting Complaint
9.2.3.2 Diagnosis and Treatment Plan
9.2.3.3 Discussion
9.2.4 Case #4 Anxiety in the Guise of a Dementia
9.2.4.1 Presenting Complaint
9.2.4.2 Diagnosis and Treatment Plan
9.2.4.3 Treatment outcome
9.2.4.4 Discussion
References
10: SAMe in the Treatment of Refractory Depression with Comorbid Anxiety: A Case Study in a H
10.1 Introduction
10.2 Case Presentation
10.2.1 Presenting Complaint
10.2.2 Assessment of Patient
10.2.3 Diagnosis and Treatment Plan
10.3 Treatment Outcome
10.4 Discussion
References
11: A Complex Case of Undiagnosed Generalised Anxiety Disorder with Episodic Panic Attacks
11.1 Introduction
11.2 Case Presentation
11.2.1 Presenting Complaint
11.3 Assessment of Patient
11.3.1 Initial Assessment
11.3.2 Ongoing Assessment
11.3.3 Diagnosis and Treatment Plan
11.3.4 Therapeutics Goals
11.3.5 Prescribed Treatment
11.4 Treatment Outcome
11.5 Discussion
11.5.1 Reflection
People also search for Evidence Based Herbal and Nutritional Treatments for Anxiety in Psychiatric Disorders 1st:
evidence-based herbal medicine
evidence based herbalism
evidence based nutrition research
what is one example of an evidence-based nutrition principle/recommendation
what does an evidence-based approach to supplements include
Tags: Evidence Based, Herbal, Nutritional Treatments, Anxiety, Psychiatric Disorders, David Camfield, Erica McIntyre, Jerome Sarris